NCT00000251 arm group f5fe5d5528b5ace469a4ab7df6c49698 [clinicaltrials_resource:NCT00000251/arm-group/f5fe5d5528b5ace469a4ab7df6c49698]
arm group [clinicaltrials_vocabulary:arm-group]
NCT00000251 arm group f5fe5d5528b5ace469a4ab7df6c49698 [clinicaltrials_resource:NCT00000251/arm-group/f5fe5d5528b5ace469a4ab7df6c49698]
Bio2RDF identifier
NCT00000251/arm-group/f5fe5d5528b5ace469a4ab7df6c49698
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltri ...... fe5d5528b5ace469a4ab7df6c49698
description [clinicaltrials_vocabulary:description]
Subjects will inhale a combination of 0.2% isoflurane and 30% N2O
identifier
clinicaltrials_resource:NCT00000251/arm-group/f5fe5d5528b5ace469a4ab7df6c49698
title
NCT00000251 arm group f5fe5d5528b5ace469a4ab7df6c49698
@en
type
label
NCT00000251 arm group f5fe5d55 ...... e5d5528b5ace469a4ab7df6c49698]
@en